Yes, Speaker, before I give the follow-up questions, I would like to say that, according to a confidential warning letter written on 29 July 2009, a copy of which was leaked to the British press, the Head of Immunisation of the UK government's Health Protection Agency warned British neurologists that the swine flu vaccine, which was briefly used in a mass vaccination programme in 1976 in the USA until it was abruptly withdrawn because of dangerous side effects, is likely to cause Guillain-Barr syndrome, GBS, which attacks the lining of the nerves, causing paralysis and the inability to breathe. It can be fatal. Obviously - and there was another study which showed that the likelihood of GBS was 800% after the immunisation - these are matters for concern.
So, the question I'm really asking is, have we looked into these concerns? Are we absolutely sure that this is not going to be problematic? Our immunisation roll-out starts on Monday, I believe. Has the vaccine ever been tested on children or expectant mothers, particularly since these are two primary groups targeted to receive the vaccine? Will you take any measures to ensure that doctors, particularly neurologists, are informed of the risks before the immunisation campaigns begin? If not, why not? And if so, what measures can you let us have? Thank you.